Stockscreener 앱 받기
22.71
3.69%
-0.87
전일 마감가:
$23.58
열려 있는:
$23.93
하루 거래량:
59,938
Relative Volume:
0.41
시가총액:
$387.16M
수익:
$978.76M
순이익/손실:
$-286.52M
주가수익비율:
-1.3111
EPS:
-17.3212
순현금흐름:
$-31.63M
1주 성능:
+5.09%
1개월 성능:
-33.42%
6개월 성능:
-16.38%
1년 성능:
-43.04%
1일 변동 폭
$22.65
$24.55
1주일 범위
$21.16
$24.55
52주 변동 폭
$11.50
$74.07
Claritev Corp Stock (CTEV) Company Profile
명칭
Claritev Corp
전화
212-780-2000
주소
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, BTSG, HQY, TEM, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
22.71 | 371.98M | 978.76M | -286.52M | -31.63M | -17.32 |
VEEV
Veeva Systems Inc
|
203.77 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
59.74 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
100.61 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
43.87 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
47.27 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | Barclays | Overweight |
| 2026-01-12 | 개시 | Guggenheim | Buy |
| 2026-01-09 | 개시 | Wells Fargo | Equal Weight |
| 2025-10-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-29 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Neutral |
| 2022-12-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-07-12 | 개시 | Goldman | Neutral |
| 2021-10-04 | 재개 | Citigroup | Buy |
| 2021-04-07 | 개시 | B. Riley Securities | Buy |
| 2021-03-19 | 개시 | Barclays | Equal Weight |
모두보기
Claritev Corp 주식(CTEV)의 최신 뉴스
Claritev™ and SAVVI Financial® Collaborate to Deliver the Next Generation of Healthcare Benefit Decision Support - TradingView
Claritev Corp (CTEV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Claritev Corp (CTEV) Institutional Confidence - TradingKey
Claritev Corp (CTEV) Income Statement - TradingKey
Claritev Corp (CTEV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Claritev Corp (CTEV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Claritev Corp (CTEV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Claritev Corp (CTEV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Claritev Corporation (CTEV) Stock Analysis: Exceptional Growth Potential with a 61.87% Upside - DirectorsTalk Interviews
Claritev Corp (CTEV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Citi Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Claritev Corp (CTEV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Claritev Corporation (CTEV) stock price, news, quote and history - Yahoo Finance Singapore
Claritev Corporation (CTEV) Stock Price, News, Quote & History - Yahoo! Finance Canada
CCORF Maintains Claritev(CTEV.US) With Buy Rating, Raises Target Price to $37 - Moomoo
Claritev Adopts CodeTogether's AITrax to Bring Greater Measurement and Accountability to AI-Assisted Development - PR Newswire
Claritev (NYSE:CTEV) Attracts S&P 500 Attention on Tech Focus - Kalkine Media
Claritev (NYSE:CTEV) Price Target Raised to $37.00 at Canaccord Genuity Group - MarketBeat
ETFs Investing in Claritev Corporation Class A Stocks - TradingView
Claritev Corporation (CTEV) Q1 2026 Earnings: EPS Falls Short of Estimates Amid Operational Challenges - dars.gov.et
DOJ deepens Claritev probe with “massive” info request - Global Competition Review
Sun Life U.S. and Claritev work to boost efficiency of supplemental health benefits - PR Newswire
Claritev Corporation Announces Second Quarter 2026 Earnings Conference Call - 01net
Claritev Corporation to announce Q2FY26 results on August 7 - scanx.trade
Press Release: Claritev Corporation Announces Second Quarter 2026 Earnings Conference Call - 富途牛牛
UnitedHealth (UNH) Faces Broader DOJ Antitrust Probe Into Claritev - simplywall.st
Form S-1 Claritev Corp For: 15 July By Investing.com - Investing.com Nigeria
Claritev (CTEV) Shares Drop 8.5% Amid Antitrust Probe Expansion - GuruFocus
DOJ’s Claritev Probe Expands With New Information Demands - Bloomberg.com
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands - Yahoo Finance
Claritev drops on report DOJ expanding antitrust probe - MSN
DOJ Broadens Antitrust Inquiry into Claritev (CTEV) - GuruFocus
DOJ’s Claritev probe intensifies with new information demands - Modern Healthcare
Claritev drops on report DOJ expanding antitrust probe (CTEV:NYSE) - Seeking Alpha
DOJ Expands Antitrust Probe of Claritev, Bloomberg Reports - marketscreener.com
Is Claritev Corp (CTEV) a Bargain After 5.0% Drop? GF Value Says Undervalued - GuruFocus
Claritev Rises to Leader Ranking in Everest Group's 2026 Pre-Payment Integrity Solutions PEAK Matrix Assessment - marketscreener.com
Claritev Corporation (CTEV) Recognized as Leader in Everest Grou - GuruFocus
Claritev Rises to Leader Ranking in Everest Group's 2026 Pre-Payment Integrity Solutions PEAK Matrix® Assessment - Business Wire
Claritev : Five Considerations for Turning Transparency into Value - marketscreener.com
Claritev (CTEV) BofA Securities Leveraged Finance Conference 2025 Summary - Quartr
Claritev Corporation Files Form 8-K: Key Details for NYSE-Listed CTEV on July 6, 2026 - Minichart
Claritev (NYSE: CTEV) reports death of board member John Prince - Stock Titan
Claritev Corporation Announces Death of Mr. John Prince , Member of Board of Directors and Audit Committee, on July 6, 2026 - marketscreener.com
Claritev Corporation (CTEV) Edges Higher: Consolidation Near Support Signals Potential UpsideChange of Character - dars.gov.et
CTEVClaritev Corp Volatility & Greeks - Finviz
Claritev Corporation (CTEV) Edges Higher as Stock Tests Key ResistanceStop Run - dars.gov.et
CTEV PE Ratio & Valuation, Is CTEV Overvalued - Intellectia AI
Claritev (CTEV) grants SVP and Chief Accounting Officer 3,649 RSUs - Stock Titan
Claritev Corporation (CTEV) Investigation: Bronstein, Gewirtz & G - The National Law Review
Claritev Corporation(NYSE: CTEV) added to Russell 2000 Value Benchmark - marketscreener.com
Claritev Corp (CTEV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Claritev Corp 주식 (CTEV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kim Michael | EVP, Chief Digital Officer |
May 18 '26 |
Buy |
16.65 |
3,000 |
49,950 |
185,878 |
| Prince John Michael | Director |
May 19 '26 |
Buy |
16.00 |
10,000 |
160,000 |
31,662 |
| Dalton Travis | Pres., CEO & Executive Chair |
May 18 '26 |
Buy |
12.36 |
20,920 |
258,638 |
45,872 |
| Garis Douglas Michael | EVP&CFO |
Mar 16 '26 |
Buy |
17.69 |
1,300 |
22,997 |
206,152 |
| Kim Michael | EVP, Chief Digital Officer |
Mar 12 '26 |
Buy |
16.50 |
15,000 |
247,500 |
182,878 |
| Kim Michael | EVP, Chief Digital Officer |
Feb 27 '26 |
Buy |
14.30 |
30,000 |
428,955 |
137,973 |
| Dalton Travis | Pres., CEO & Executive Chair |
Feb 27 '26 |
Buy |
13.00 |
15,380 |
199,928 |
24,952 |
| O'Neil Tara | SVP, General Counsel |
Mar 02 '26 |
Buy |
12.99 |
750 |
9,742 |
27,199 |
| Dalton Travis | Pres., CEO & Executive Chair |
Nov 20 '25 |
Buy |
47.23 |
5,290 |
249,842 |
9,572 |
| Mintz William B. | SVP, Chief Strategy Officer |
Nov 17 '25 |
Buy |
38.00 |
916 |
34,808 |
65,325 |
0.84%
0.79%
자본화:
|
볼륨(24시간):